December 17, 2021
Danimer Scientific, Inc., a leading next generation bioplastics company focused on the development and production of biodegradable materials, has announced the pricing of its offering of US$200,000,000 aggregate principal amount of 3.250% convertible senior notes due 2026 in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The offering size was increased from the previously announced offering size of US$175,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on December 21, 2021, subject to customary closing conditions. Danimer also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional US$40,000,000 aggregate principal amount of notes.
Latham & Watkins LLP represents the initial purchasers in the offering with a capital markets team led by partners Greg Rodgers, Erika Weinberg, Marc Jaffe, and Ian Schuman, with associates Shawn Quinn, Alexandra Kustra, and Kevin Zhang. Advice was also provided on equity derivatives matters by partner Catherine Lee, with associates Eric Rice, Paul Lau, and Yi Wei; on intellectual property matters by partner Jeffrey Tochner, with associate Dewey Kang; on environmental matters by partner James Barrett, with associate Phil Sandick; and on tax matters by partner Bora Bozkurt, with Jacob Nagelberg.